Silence is golden: Gene hypermethylation and survival in large-cell lymphoma

Journal of the National Cancer Institute

Volumn 94, Issue 1, 2002, Pages 6-7

  Dolan, M Eileen ^a   Schilsky, Richard L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 O BENZYLGUANINE; ACROLEIN; CARBOPLATIN; CARMUSTINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PHOSPHORAMIDE MUSTARD; PROCARBAZINE; TEMOZOLOMIDE;

ANIMAL CELL; CANCER SURVIVAL; CONTROLLED STUDY; DNA CROSS LINKING; DNA METHYLATION; DNA MICROARRAY; DNA REPAIR; DRUG RESPONSE; DRUG SENSITIVITY; EDITORIAL; ENZYME ACTIVITY; GENE SILENCING; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; MOLECULAR BIOLOGY; NONHUMAN; OVARY CARCINOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION;

EID: 0037005898     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.1.6     Document Type: Editorial

References (25)

1. Prognostic factors for hematologic cancers
2. Towards a novel classification of human malignancies based on gene expression patterns
3. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
4. 6-methylguanine-DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma
5. 6-alkylguanine-DNA alkyltransferase
6. 6-alkylguanine by alkyltransferases
7. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
8. 6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells
9. 6-methylguanine-DNA methyltransferase expression in human rhabdomyosarcoma cell lines and xenografts
10. An overview of cyclophosphamide development and clinical applications
11. Isophosphamide as a new acrolein-producing antineoplastic isomer of cyclophosphamide
12. The development of mesna for the inhibition of urotoxic side effects of cyclophosphamide, ifosfamide, and other oxazaphosphorine cytostatics
13. Evaluation of the mutagenic potential of the principal DNA adduct of acrolein
14. A structural basis for a phosphoramide mustard-induced DNA interstrand cross-link at 5′-d(GAC)
15. 6-alkylguanine-DNA alkyltransferase
16. 6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity
17. Increased susceptibility to chemotherapeutic alkylating agents of mice deficient in DNA repair methyltransferase
18. 6-methylguanine-DNA methyltransferase (MGMT) on the cytotoxic and recombinogenic activity of different antineoplastic drugs
19. 6-methylguanine-DNA methyltransferase activity and sensitivity to cyclophosphamide and cisplatin in human lung tomor xenografts
20. Activity of O(6)-methylguanine-DNA methyltransferase in relation to p53 status and therapeutic response in ovarian cancer
21. 6-methylguanine-DNA methyltransferase in ovarian malignancy and its correlation with postoperative response to chemotherapy
22. 6-alkylguanine-DNA-alkyltransferase of human tumour xenografts. EORTC SPG and PAMM Groups
23. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents
24. 6-benzylguanine on nitrogen mustard-induced toxicity, apoptosis, and mutagenicity in Chinese hamster ovary cells
25. 6-alkylguanine-DNA alkyltransferase